Zai Lab Ltd

ZLAB

Company Profile

  • Business description

    Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

  • Contact

    899 Halei Road
    Building B
    Pudong
    Shanghai201203
    CHN

    T: +86 2161632588

    E: [email protected]

    https://www.zailaboratory.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    1,797

Stocks News & Analysis

stocks

Apple earnings: A smooth transition despite continued memory and supply headwinds

Shares fell as investors digested the latest earnings.
stocks

Two new ASX names added to our Global Best Stock Ideas

Our full global list includes 78 companies from around the world.
stocks

Big four bank holds up in weakening economic conditions

Major bank earnings hold up in challenging conditions.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,954.9054.00-0.60%
CAC 408,093.6173.300.91%
DAX 4026,123.26258.641.00%
Dow JONES (US)51,786.72197.26-0.38%
FTSE 10010,709.5771.140.67%
HKSE23,919.50393.531.67%
NASDAQ25,372.01207.650.83%
Nikkei 22562,188.63893.23-1.42%
NZX 50 Index13,783.4563.190.46%
S&P 5007,568.9227.520.36%
S&P/ASX 2008,834.5052.30-0.59%
SSE Composite Index3,686.1778.072.16%

Market Movers